Cargando…

Ethanol Sclerosis Therapy for Aggressive Vertebral Hemangioma of the Spine: A Narrative Review

Vertebral hemangiomas of the spine are rare benign tumors. They occur primarily in the thoracic region and are often asymptomatic and found incidentally on radiological examination; however, some are symptomatic, aggressive, and gradually increase in size. Various therapeutic approaches have been pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tonosu, Juichi, Yamaguchi, Yasuteru, Higashikawa, Akiro, Watanabe, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298994/
https://www.ncbi.nlm.nih.gov/pubmed/37373622
http://dx.doi.org/10.3390/jcm12123926
_version_ 1785064253721411584
author Tonosu, Juichi
Yamaguchi, Yasuteru
Higashikawa, Akiro
Watanabe, Kenichi
author_facet Tonosu, Juichi
Yamaguchi, Yasuteru
Higashikawa, Akiro
Watanabe, Kenichi
author_sort Tonosu, Juichi
collection PubMed
description Vertebral hemangiomas of the spine are rare benign tumors. They occur primarily in the thoracic region and are often asymptomatic and found incidentally on radiological examination; however, some are symptomatic, aggressive, and gradually increase in size. Various therapeutic approaches have been proposed for their management. This study aimed to review the therapeutic management, focusing on ethanol sclerosis therapy. The PubMed database was searched from inception to January 2023 using the keywords “hemangioma”, “spine OR vertebra”, and “ethanol”. Twenty studies were retrieved, including two letters. The first report of spinal therapy was published in 1994. Ethanol sclerosis therapy is effective in treating vertebral hemangiomas. It is performed independently or in combination with other techniques, such as vertebroplasty using cement and surgery. The therapy is performed under local or general anesthesia with fluoroscopic or computed tomography guidance. A total of 10–15 mL of ethanol is slowly injected via unilateral or bilateral pedicles. Complications of the therapy include hypotension and arrhythmia during the procedure, paralysis immediately after the procedure, and delayed compression fractures. This review could enable the refinement of knowledge regarding ethanol sclerosis therapy, which is a treatment option that could be adopted.
format Online
Article
Text
id pubmed-10298994
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102989942023-06-28 Ethanol Sclerosis Therapy for Aggressive Vertebral Hemangioma of the Spine: A Narrative Review Tonosu, Juichi Yamaguchi, Yasuteru Higashikawa, Akiro Watanabe, Kenichi J Clin Med Review Vertebral hemangiomas of the spine are rare benign tumors. They occur primarily in the thoracic region and are often asymptomatic and found incidentally on radiological examination; however, some are symptomatic, aggressive, and gradually increase in size. Various therapeutic approaches have been proposed for their management. This study aimed to review the therapeutic management, focusing on ethanol sclerosis therapy. The PubMed database was searched from inception to January 2023 using the keywords “hemangioma”, “spine OR vertebra”, and “ethanol”. Twenty studies were retrieved, including two letters. The first report of spinal therapy was published in 1994. Ethanol sclerosis therapy is effective in treating vertebral hemangiomas. It is performed independently or in combination with other techniques, such as vertebroplasty using cement and surgery. The therapy is performed under local or general anesthesia with fluoroscopic or computed tomography guidance. A total of 10–15 mL of ethanol is slowly injected via unilateral or bilateral pedicles. Complications of the therapy include hypotension and arrhythmia during the procedure, paralysis immediately after the procedure, and delayed compression fractures. This review could enable the refinement of knowledge regarding ethanol sclerosis therapy, which is a treatment option that could be adopted. MDPI 2023-06-08 /pmc/articles/PMC10298994/ /pubmed/37373622 http://dx.doi.org/10.3390/jcm12123926 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tonosu, Juichi
Yamaguchi, Yasuteru
Higashikawa, Akiro
Watanabe, Kenichi
Ethanol Sclerosis Therapy for Aggressive Vertebral Hemangioma of the Spine: A Narrative Review
title Ethanol Sclerosis Therapy for Aggressive Vertebral Hemangioma of the Spine: A Narrative Review
title_full Ethanol Sclerosis Therapy for Aggressive Vertebral Hemangioma of the Spine: A Narrative Review
title_fullStr Ethanol Sclerosis Therapy for Aggressive Vertebral Hemangioma of the Spine: A Narrative Review
title_full_unstemmed Ethanol Sclerosis Therapy for Aggressive Vertebral Hemangioma of the Spine: A Narrative Review
title_short Ethanol Sclerosis Therapy for Aggressive Vertebral Hemangioma of the Spine: A Narrative Review
title_sort ethanol sclerosis therapy for aggressive vertebral hemangioma of the spine: a narrative review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298994/
https://www.ncbi.nlm.nih.gov/pubmed/37373622
http://dx.doi.org/10.3390/jcm12123926
work_keys_str_mv AT tonosujuichi ethanolsclerosistherapyforaggressivevertebralhemangiomaofthespineanarrativereview
AT yamaguchiyasuteru ethanolsclerosistherapyforaggressivevertebralhemangiomaofthespineanarrativereview
AT higashikawaakiro ethanolsclerosistherapyforaggressivevertebralhemangiomaofthespineanarrativereview
AT watanabekenichi ethanolsclerosistherapyforaggressivevertebralhemangiomaofthespineanarrativereview